A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 1 / Phase 2	2026-02-10		NCT06064812

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Forward Pharmaceuticals Co., Ltd.	3

22 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
First Affiliated Hospital of China Medical University	Shenyang	China	2
Fudan University Shanghai Cancer Center	Shanghai	China	257
Guangxi Medical University Cancer Hospital	Nanning	China	24
Henan Cancer Hospital	Zhengzhou	China	98
Hubei Cancer Hospital	Wuhan	China	32
Huizhou First Hospital	Huizhou	China	2
Jiangsu Province Hospital	Nanjing	China	37
Jilin Cancer Hospital	Changchun	China	24
Liaoning Cancer Hospital & Institute	Shenyang	China	14
Shandong Cancer Hospital	Jinan	China	31
Sichuan Cancer Hospital	Chengdu	China	30
Sir Run Run Shaw Hospital,affiliated with Zhejiang University School of Medicine	Hangzhou	China	1
Sun Yat-Sen University Cancer Center	Guangzhou	China	113
The Central Hospital of Yongzhou	Yongzhou	China	7
The First Affiliated Hospital of Henan University of Science & Technology	Luoyang	China	14
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	103
The First Hospital of Jilin University	Changchun	China	46
The Second Hospital of Anhui Medical University	Hefei	China	21
The second people's hospital of Yibin	Yibin	China	3
Tianjin Medical University Cancer Institute & Hospital	Tianjin	China	23
Xinxiang Central Hospital	Xinxiang	China	8
Zhejiang Cancer Hospital	Hangzhou	China	84

Clinical trials